Daily Respiratory Research Analysis
Analyzed 126 papers and selected 3 impactful papers.
Summary
Among 126 respiratory-themed papers, three stood out for immediate or near-term impact: an open-label randomized trial from Vietnam showing antenatal dexamethasone reduces respiratory support and NICU admissions in late preterm infants; a nationwide French case-control analysis identifying NO2 and extreme cold as key exposome drivers of severe COPD/asthma exacerbations; and a registered systematic review/meta-analysis linking outdoor combustion-related pollutants to adolescent asthma risk.
Research Themes
- Perinatal corticosteroids to reduce neonatal respiratory morbidity
- Environmental exposures (NO2, cold) driving obstructive disease exacerbations
- Air pollution and adolescent asthma risk (evidence synthesis)
Selected Articles
1. Impact of Antenatal Dexamethasone on Respiratory Outcomes in Late Preterm Infants in a Vietnamese Tertiary Hospital: A Randomised Controlled Trial.
In an open-label RCT (n=294) from Vietnam, antenatal dexamethasone reduced postnatal respiratory support (15% vs 24.5%) and neonatal unit admissions without increasing maternal infection or neonatal hypoglycaemia. Findings support extending antenatal corticosteroid benefits to late preterm populations in low- and middle-income settings.
Impact: High-quality randomized evidence shows a clinically meaningful reduction in immediate neonatal respiratory morbidity with a widely available intervention.
Clinical Implications: Consider incorporating antenatal dexamethasone into protocols for women at risk of late preterm delivery to reduce newborn respiratory support and NICU admissions, especially where neonatal intensive care capacity is limited.
Key Findings
- Postnatal respiratory support was lower with dexamethasone versus control (15% vs 24.5%, p=0.04).
- Neonatal unit admissions were significantly reduced in the dexamethasone group (p=0.01).
- Phototherapy-requiring jaundice was higher in controls; no increase in maternal infection or neonatal hypoglycaemia with dexamethasone.
Methodological Strengths
- Randomised controlled design with intention-to-treat analysis
- Prospective trial registration (ClinicalTrials.gov NCT05841121)
Limitations
- Open-label design without blinding may introduce performance/detection bias
- Single-country setting may limit generalizability across health systems
Future Directions: Head-to-head comparisons of dexamethasone vs betamethasone in late preterm populations; cost-effectiveness and long-term neurodevelopmental outcomes in diverse settings.
AIM: To assess the effect of antenatal dexamethasone on reducing the need for respiratory support in late preterm infants. METHODS: The study was an open-label randomised controlled trial. Participants included 294 pregnant women at risk of late preterm delivery, admitted to Da Nang Hospital for Women and Children, Vietnam. Women in the intervention group received antenatal dexamethasone, compared with standard care for the control group. Statistical analysis was conducted using STATA 18 with an intention-to-treat approach. Comparisons were performed using the chi-squared test or Fisher's exact test for categorical data and the unpaired t-test or Wilcoxon rank-sum test for continuous data. RESULTS: Infants in the control group required respiratory support after birth more frequently than those in the dexamethasone group (24.5% vs. 15%, p = 0.04). The neonatal unit admission rate was significantly higher in the control group (p = 0.01), with respiratory problems accounting for the most common reason for admission. Regarding morbidities, jaundice requiring phototherapy was significantly higher in the control group. CONCLUSION: Antenatal dexamethasone significantly reduced the need for respiratory support after birth and neonatal unit admission. Dexamethasone administration was not associated with increased maternal postnatal infection or neonatal hypoglycaemia. TRIAL REGISTRATION: ClinicalTrial.gov NCT05841121.
2. Unravelling the exposome of severe exacerbations of obstructive respiratory diseases in France.
This nationwide matched case-control study linking hospitalizations with environmental open data found that extreme cold and NO2 exceedance were associated with severe exacerbations of COPD and asthma. The exposome approach highlighted modifiable risk factors at scale, informing both patient-level counseling and public health policy.
Impact: Very large, real-world analysis identifies actionable environmental drivers of severe exacerbations, providing targets for prevention and health system planning.
Clinical Implications: Advise high-risk patients to mitigate cold exposure (e.g., heating, protective clothing) and monitor NO2 alerts; health systems should integrate environmental risk alerts into care pathways and advocate for air quality improvements.
Key Findings
- Nationwide matched case-control analysis (COPD n=473,990; asthma n=187,332) quantified exposome associations with severe exacerbations.
- Extreme cold temperature exposure and NO2 levels exceeding WHO standards were associated with increased exacerbation risk.
- Study demonstrates feasibility and utility of linking hospital data with environmental open data to identify modifiable risks.
Methodological Strengths
- Very large, nationally representative matched case-control design
- Integration of clinical and environmental open datasets with conditional logistic regression
Limitations
- Potential residual confounding and exposure misclassification (area-level measures)
- Causality cannot be inferred from observational design
Future Directions: Prospective cohorts with personal exposure monitoring and time-series interventions (e.g., air quality alerts) to test mitigation strategies and quantify attributable risk.
INTRODUCTION: Understanding the influence of environmental and socioeconomic factors, collectively known as the exposome, on severe exacerbation risks in chronic obstructive pulmonary disease (COPD) and asthma is crucial for enhancing patient care. METHODS: We assessed the impact of the exposome on COPD and asthma severe exacerbations in France between 2018 and 2022, combining data from the French National Hospital Discharge Programme de Médicalisation des Systèmes d'Information database and open data for multiple environmental exposition. Using a retrospective matched case-control design, 473 990 patients with COPD and 187 332 patients with asthma were matched for sex, birth year and date of first hospitalisation. Conditional logistic regressions were performed to quantify ORs of exacerbations within the studied population. RESULTS: In a multivariate model, exposure to extreme cold temperatures and exceeding WHO standards for nitrogen dioxide (NO
3. Outdoor air pollutants and asthma risk in adolescents: evidence from a systematic review and meta-analysis.
Registered meta-analysis of 40 studies found significant associations between outdoor combustion-related pollutants and adolescent asthma risk, despite heterogeneity across designs and exposure assessments. The work prioritizes standardized exposure metrics and life-course, multipollutant approaches for future studies.
Impact: Synthesizes a fragmented evidence base into pooled estimates supporting causally plausible links between pollution and adolescent asthma, informing prevention and policy.
Clinical Implications: Clinicians should incorporate air quality risk counseling for adolescents with atopy or respiratory symptoms and support community-level interventions to reduce combustion-related pollutant exposure.
Key Findings
- Systematic review and meta-analysis (40 of 51 eligible studies) demonstrated significant associations between outdoor combustion-related pollutants and adolescent asthma.
- Heterogeneity across study designs, exposure assessments, and asthma definitions contributed to variability in pooled estimates.
- Study was registered in PROSPERO (CRD42024622246), enhancing transparency and methodological rigor.
Methodological Strengths
- Prospective registration (PROSPERO) with comprehensive database searches
- Use of fixed- and random-effects models with heterogeneity assessment
Limitations
- Exposure misclassification and varied outcome definitions across observational studies
- Potential publication bias and residual confounding cannot be excluded
Future Directions: Standardize exposure metrics (e.g., spatiotemporal pollutant models), adopt life-course cohorts, and apply multipollutant statistical frameworks to refine risk attribution.
BACKGROUND: Existing epidemiological evidence linking outdoor air pollution to asthma incidence in adolescents remains inconclusive, due to methodological heterogeneity in study design, exposure assessment, and asthma case definitions. METHODS: This systematic review and meta-analysis synthesized observational studies examining associations between outdoor air pollutants and adolescent asthma. Comprehensive searches of PubMed, Embase, and Scopus were conducted using Medical Subject Headings (MeSH) and free-text terms. Eligible studies reported quantitative estimates, odds ratio (OR), hazard ratio (HR), relative risk (RR), prevalence ratio (PR), incidence rate ratio (IRR), or prevalence odds ratio (POR), with corresponding 95% confidence interval (CI). Pooled estimates were calculated using inverse-variance weighted fixed- and random-effects models. Heterogeneity was assessed using Cochran's RESULTS: Of 51 eligible studies, 40 were incorporated into the meta-analysis. Statistically significant associations were identified for each 10 μg/m CONCLUSION: This meta-analysis highlights significant associations between adolescent asthma and specific combustion-related air pollutants. Future research should prioritize standardized exposure metrics, life-course cohort designs, and multipollutant modeling to inform targeted prevention and public health strategies. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/, identifier PROSPERO database (CRD42024622246).